About 1 in 10 people say gluten upsets their stomach or leaves them tired and foggy. Some of them have celiac disease, some have a wheat allergy, and many have what doctors call non-celiac gluten sensitivity, often called gluten intolerance. Supplement shelves offer "gluten digestion" enzymes, probiotics and gut-repair blends for all of them.

The short answer on supplements: none of them replaces a diagnosis, and none makes gluten safe for someone with celiac disease.

The short version

  • Get tested for celiac disease before cutting gluten. Celiac blood tests and biopsies can come back falsely normal once you go gluten-free, and symptoms alone cannot tell celiac disease apart from gluten sensitivity.
  • The symptoms are real, but gluten itself is often not the trigger. In a review of 10 blinded trials, only 16 percent of people with suspected gluten sensitivity reacted to gluten specifically, and in one trial wheat fibers called fructans caused more symptoms than gluten did.
  • Enzymes do not make gluten safe. One enzyme (AN-PEP, sold as Tolerase G) breaks down gluten in the stomach in feeding studies, but it has not been shown to prevent symptoms or gut damage, and most "gluten digestion" blends leave the problem fragments largely intact. They are never a substitute for a gluten-free diet in celiac disease.
  • The best-supported help is dietary. A dietitian-led low-FODMAP diet (cutting certain fermentable carbohydrates for a few weeks, then adding them back one at a time) has the most trial evidence for IBS-type gut symptoms. Peppermint oil and psyllium have evidence in IBS, not in gluten sensitivity itself.
  • Watch for nutrient gaps. Gluten-free diets tend to run low in fiber, iron, folate and other B vitamins, calcium and vitamin D.
  • See a doctor for weight loss, anemia, blood in the stool, persistent diarrhea, a family history of celiac disease or a blistering rash.

Celiac disease, wheat allergy or gluten sensitivity

Gluten is a group of proteins in wheat, barley and rye. Three different conditions can make people react to foods that contain it, and they are not interchangeable.

ConditionWhat it isHow it is diagnosedWhat it means
Celiac diseaseAn autoimmune reaction to gluten that damages the small intestineAntibody blood tests (tTG-IgA, explained below), usually confirmed by biopsy, while still eating glutenStrict lifelong gluten-free diet and medical follow-up
Wheat allergyA true food allergy to wheat proteins (driven by IgE antibodies), which can be severeAn allergist, with skin or blood tests and sometimes a supervised food challengeAvoid wheat; barley and rye may be fine
Non-celiac gluten sensitivityGut and body symptoms after eating gluten-containing foods, without celiac disease or wheat allergyBy exclusion: there is no test for itReduce the trigger foods as much as needed for comfort

Celiac disease affects roughly 1 percent of people: a 2018 analysis of studies worldwide found 1.4 percent by blood test and 0.7 percent by biopsy. It runs in families, affecting about 10 percent of first-degree relatives (parents, siblings and children). Non-celiac gluten sensitivity has no test or biomarker, so it is diagnosed only after celiac disease and wheat allergy are ruled out. Because the trigger may be something in wheat other than gluten, some researchers call it non-celiac wheat sensitivity.

Gluten sensitivity symptoms

In a 2025 analysis of 25 studies with nearly 50,000 people from 16 countries, 10.3 percent said they were sensitive to gluten or wheat. The most common symptoms they reported were:

People also report diarrhea or constipation, headaches, "brain fog," joint aches and low mood. Self-reported gluten sensitivity was more common in women and closely tied to irritable bowel syndrome (IBS), anxiety and depression, which is why researchers increasingly see it as overlapping with IBS and other gut-brain conditions.

The catch is that celiac disease can cause the very same symptoms. A JAMA review put it plainly: doctors cannot tell the two apart by symptoms. An itchy, blistering rash (dermatitis herpetiformis) is a skin form of celiac disease, not of gluten sensitivity.

See a doctor rather than self-treat if you have
  • Unexplained weight loss, iron-deficiency anemia, blood in the stool or black stools, persistent diarrhea, vomiting, trouble swallowing, night-time symptoms or fever.
  • New bowel changes after age 50, or a family history of celiac disease, inflammatory bowel disease or bowel cancer.
  • An itchy blistering rash, early osteoporosis, type 1 diabetes or autoimmune thyroid disease, or a child with poor growth.
About 1 in 31 people with iron-deficiency anemia turned out to have celiac disease in a pooled analysis of biopsy studies.

Gluten sensitivity tests: why celiac testing comes first

Celiac blood tests and biopsies look for the damage and antibodies that gluten causes. Once you stop eating gluten, those signs fade, and the tests can come back falsely normal. The American Gastroenterological Association says cutting back on gluten before testing is discouraged for exactly this reason, and European and British guidelines say testing should happen on a gluten-containing diet.

Knowing matters. Celiac disease needs a strict, lifelong diet and follow-up for nutrient deficiencies and bone health, while gluten sensitivity usually allows a much looser approach. Home "food sensitivity" kits do not diagnose either one; see our guide to at-home gut and food sensitivity tests.

Is gluten sensitivity real? What blinded trials show

The fairest way to test gluten sensitivity is a blinded challenge: people who feel better off gluten eat foods or capsules that secretly contain gluten or a placebo, and nobody knows which until the end. These trials have produced some surprises.

Researchers are also studying other wheat proteins called amylase-trypsin inhibitors, which stimulate the immune system in lab and animal studies. Whether they cause symptoms in people has not been shown, and a 2025 lab study suggested that bacterial contamination may explain much of the immune effect seen in cell tests.

The fair reading: a minority of people with gluten sensitivity react to gluten itself, many react to fructans or other parts of wheat, and expectation plays a real role (the nocebo effect: expecting a food to make you sick can bring on real symptoms). None of this means the symptoms are imagined. It means that avoiding all gluten forever may not be necessary, and that the trigger is worth pinning down.

Low-FODMAP: the diet approach with the most evidence

For gut symptoms, the best-studied option, tested mainly in people with IBS, is a low-FODMAP diet done in three steps: a few weeks cutting high-FODMAP foods (including wheat, onions, garlic, beans and some fruits), then reintroducing them one group at a time to find your triggers, then a personalized long-term diet. In a 2022 analysis of 13 randomized trials in IBS, it ranked first of the diets studied, and a 2025 analysis of 28 IBS trials found the most evidence for it, and it was the only diet that beat a usual diet for bloating, though most comparisons were of low or very low certainty.

A dietitian helps here, because the elimination phase is restrictive and is not meant to last. Because wheat is a major fructan source, many people who feel better gluten-free may simply be eating fewer FODMAPs, and some find they tolerate sourdough or small amounts of wheat after reintroduction. Fructan-digesting enzymes such as fructanase act on fructans only and do nothing for gluten.

Gluten-digesting enzymes

"Gluten digestion" enzymes are the most heavily marketed supplements in this space. The evidence splits into three groups.

AN-PEP (Tolerase G, also sold as GliadinX). This enzyme, a prolyl endopeptidase made from the mold Aspergillus niger (hence AN-PEP), cuts gluten at the points other enzymes miss. In feeding studies, some run with its manufacturer, it broke down most of the gluten in the stomach: in 18 gluten-sensitive people eating a porridge with 0.5 g of gluten, stomach gluten exposure on the high dose was about 88 percent lower than on placebo (median 22.0 versus 176.9). Breaking gluten down in the stomach is not the same as preventing symptoms, though:

Multi-enzyme blends. One blend sold to brands as GluteAX was tested in a single-blind trial of 30 people whose symptoms rose during an open (unblinded) gluten challenge, run and funded by the enzyme maker. A combined symptom score improved, while most individual symptoms and inflammation markers did not change. One small industry trial is not enough to rely on.

DPP-IV and general digestive-enzyme blends. DPP-IV (dipeptidyl peptidase IV) is a protein-cutting enzyme found in many "gluten digestion" formulas. Lab tests of over-the-counter products found that they leave the gluten fragments that trigger celiac reactions largely intact. A study of 14 "gluten digestion" products called them a potential hazard in celiac disease and found their claims had no scientific basis. See our DPP-IV page and digestive enzyme ranking for what these blends are used for.

Enzyme drug candidates for celiac disease are tested as medicines, not sold as supplements, and none is approved: latiglutenase did not beat placebo in a phase 2 trial of 494 people, and TAK-062 was dropped in 2025 after its phase 2 trial missed its main goal. A 2014 British guideline said none of the novel treatments could yet be recommended outside clinical trials.

Enzymes and celiac disease
  • No enzyme supplement has been shown to let someone with celiac disease eat gluten or to protect against cross-contamination. A strict gluten-free diet is the only treatment.
  • Only if celiac disease has been ruled out: if you have gluten sensitivity and want to try AN-PEP, keep expectations modest. It has not been shown to prevent symptoms, and it is not permission to eat gluten freely.

Probiotics, peppermint oil, fiber and other supplements

Probiotics. A few small trials in celiac disease found possible symptom benefits with one strain (Bifidobacterium infantis NLS), mostly in exploratory measures, and it did not change gut permeability. A two-strain B. breve product lowered an inflammation marker (TNF-alpha) in children with celiac disease, but that trial did not report a symptom benefit. For gluten sensitivity itself, we found only one small open-label study and no randomized probiotic trial as of November 2026. Strain-specific evidence for IBS is in our probiotic strains for IBS guide.

Peppermint oil. We found no trial in gluten sensitivity or celiac disease. For IBS, a 2022 meta-analysis of 10 trials in 1,030 adults favored enteric-coated peppermint oil for overall symptoms and pain, at very low certainty. See peppermint oil for IBS.

Fiber and psyllium. Gluten-free diets are often low in fiber. Psyllium, which is naturally gluten-free (look for a certified product), helped more people with IBS than placebo in a primary-care trial of 275 patients, while bran beat placebo only in the third month and not in a stricter analysis. We found no psyllium trial in gluten sensitivity specifically. Our fiber supplement ranking compares options.

Other gut products. We found no trial in people with gluten sensitivity or celiac disease for L-glutamine, zinc carnosine, digestive bitters or "leaky gut" blends (searched November 2026). A blood marker called zonulin was higher in one study of gluten sensitivity, and its authors proposed it as a marker, but it is not a validated clinical test and no supplement has been shown to change it in this condition. Our leaky gut guide covers what is and is not known.

Nutrient gaps on a gluten-free diet

Cutting gluten often means cutting fortified bread, cereal and pasta, and gluten-free versions are frequently unfortified. Studies of gluten-free diets have found low intakes of:

Celiac disease adds poor absorption. In a Dutch study of 80 newly diagnosed adults, 87 percent had at least one low nutrient value: low zinc in 67 percent, low iron stores in 46 percent, low folate in 20 percent and low B12 in 19 percent. British guidelines advise checking calcium and vitamin D at diagnosis and replacing what is low, then checking blood count, iron stores, folate, B12 and calcium at yearly follow-up.

If you eat gluten-free long term, a dietitian review and blood tests tell you what you actually need, rather than guessing. A standard multivitamin can cover small gaps; see do you need a multivitamin, and our deficiency guides for iron (plus our low iron hub), folate, vitamin B12, vitamin D and zinc.

Who should be careful

A gluten-free diet is safe when it is well planned, but it has costs. Gluten-free foods cost more, and people on gluten-free diets in a US national survey had higher blood mercury, lead and cadmium and higher urinary arsenic, possibly from rice and fish, which the authors named as suspected sources; the health effect is unknown. A large US study found no link between gluten intake and heart disease, and its authors warned that avoiding gluten without celiac disease can mean eating fewer whole grains. Very restrictive diets can also feed anxious or disordered eating, so be wary of cutting more and more foods without guidance.

Before you cut gluten or try a supplement
  • Test first. Get tested for celiac disease while still eating gluten; going gluten-free first can hide it.
  • Celiac disease needs a strict diet, not enzymes. No supplement protects against gluten exposure.
  • Children and pregnancy. Do not restrict a child's gluten before testing; a pediatric gastroenterologist should guide it. In pregnancy, keep folate intake up, since gluten-free foods are often unfortified, and talk with your clinician.
  • Red-flag symptoms such as weight loss, anemia or blood in the stool need a medical evaluation.

Frequently asked questions

What are the symptoms of gluten sensitivity or gluten intolerance?

The most common are bloating, abdominal discomfort or pain, and fatigue; people also report diarrhea or constipation, headaches, brain fog, joint aches and low mood. In a 2025 analysis of nearly 50,000 people, bloating was reported by 71 percent of those who said gluten bothered them. Celiac disease can cause the same symptoms, so symptoms alone cannot tell them apart.

Is there a test for gluten sensitivity?

Not for gluten sensitivity itself, but celiac disease must be tested for first. Ask your doctor for celiac testing, usually a tissue transglutaminase IgA blood test with a total IgA level, while you are still eating gluten. If it is positive, a biopsy usually confirms it. Gluten sensitivity is diagnosed only after celiac disease and wheat allergy are ruled out. Home food sensitivity kits do not diagnose either one.

Should I stop eating gluten before getting tested?

No. Celiac blood tests and biopsies can come back falsely normal once you cut gluten, and the American Gastroenterological Association discourages reducing gluten before testing. If you have already stopped, your doctor may suggest a supervised gluten challenge, about 3 slices of wheat bread a day for 1 to 3 months, before testing.

How long does gluten sensitivity last?

We found no long-term studies showing whether gluten sensitivity is lifelong. Because many people react to fructans or other parts of wheat rather than gluten, some find after a structured low-FODMAP trial and reintroduction that they tolerate small amounts of wheat or sourdough. It is reasonable to recheck your tolerance with a dietitian over time. Celiac disease, by contrast, is lifelong and needs a strict gluten-free diet.

Do gluten-digesting enzymes work?

Partly, and never for celiac disease. One enzyme, AN-PEP (Tolerase G), breaks down much of the gluten in the stomach in feeding studies, but it has not been shown to prevent symptoms or gut damage, and most other gluten digestion blends leave the problem gluten fragments largely intact in lab tests. No enzyme lets people with celiac disease eat gluten.

Is gluten sensitivity real?

The symptoms are real, but gluten itself is often not the trigger. In a review of 10 blinded trials, 16 percent of people with suspected gluten sensitivity reacted to gluten specifically, and in another trial wheat fructans caused more symptoms than gluten. Expectation also plays a role. That is why pinning down your own trigger is worth more than avoiding gluten forever.

What are the best supplements for gluten intolerance?

No supplement has been shown to work for gluten sensitivity itself, and none makes gluten safe in celiac disease. A dietitian-led low-FODMAP diet with careful reintroduction has the most trial evidence for IBS-type gut symptoms, and some people find they tolerate small amounts of wheat or sourdough afterward. Peppermint oil and psyllium have evidence in IBS, though not in gluten sensitivity itself. Probiotic evidence is limited to small exploratory studies.

Do I need supplements on a gluten-free diet?

Possibly. Gluten-free diets tend to be low in fiber, iron, folate and other B vitamins, calcium and vitamin D, partly because gluten-free breads and pasta are often unfortified. People with celiac disease are often low in zinc, iron, folate and B12 at diagnosis. Blood tests and a dietitian review tell you what you need; a standard multivitamin can cover small gaps.

The bottom line

Many people feel unwell after eating wheat, and those symptoms are real. Careful trials show that gluten itself is the trigger for a minority of them, with fructans in wheat, other wheat components and expectation likely explaining much of the rest. The first step is always a celiac test while you still eat gluten, because celiac disease looks the same and needs a strict, lifelong diet.

After that, the best-supported help is a structured low-FODMAP trial with reintroduction, ideally with a dietitian (its evidence comes mainly from IBS trials), plus attention to fiber, iron, B vitamins, calcium and vitamin D if you eat gluten-free. Enzymes break down some gluten in the stomach but have not been shown to prevent symptoms, and none is a substitute for a gluten-free diet in celiac disease. Peppermint oil and psyllium have IBS evidence worth discussing with your doctor if symptoms continue.

VS
Reviewed for accuracy by
Vladimir Salamakha

B.S. in Chemistry, University of South Florida · a formulation scientist with 15 years developing compliant, evidence-based products across nutritional supplements and personal care. More about the author →

A quick note This article is general information about research on gluten sensitivity, not medical advice, and nothing here suggests that a supplement can diagnose, treat, cure, or prevent any disease. If you have digestive symptoms, suspect celiac disease, take prescription medicines, or are pregnant or breastfeeding, talk with your doctor before changing your diet or taking supplements.
Sources
Singh P et al. Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol, 2018. PMID 29551598 (celiac disease prevalence, 1.4 percent by blood test and 0.7 percent by biopsy). · Ludvigsson JF et al. Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut, 2014. PMID 24917550 (British guideline: test on gluten, gluten challenge, monitoring, novel treatments not for use outside trials). · Husby S et al. AGA Clinical Practice Update on Diagnosis and Monitoring of Celiac Disease-Changing Utility of Serology and Histologic Measures: Expert Review. Gastroenterology, 2019. PMID 30578783 (AGA update: avoid cutting gluten before testing; 3 slices of wheat bread daily for 1 to 3 months before retesting). · Al-Toma A et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterol J, 2019. PMID 31210940 (European guideline: test on a gluten-containing diet). · Leonard MM et al. Celiac Disease and Nonceliac Gluten Sensitivity: A Review. JAMA, 2017. PMID 28810029 (symptoms cannot separate celiac disease from gluten sensitivity; test before a gluten-free diet). · Catassi C et al. Diagnosis of Non-Celiac Gluten Sensitivity (NCGS): The Salerno Experts' Criteria. Nutrients, 2015. PMID 26096570 (Salerno criteria for non-celiac gluten sensitivity). · Shiha MG et al. Global prevalence of self-reported non-coeliac gluten and wheat sensitivity: a systematic review and meta-analysis. Gut, 2025. PMID 41151790 (self-reported gluten or wheat sensitivity in 10.3 percent of 49,476 people; symptom frequencies). · Biesiekierski JR et al. Non-coeliac gluten sensitivity. Lancet, 2025. PMID 41138740 (review: diagnosis of exclusion; 16 to 30 percent gluten-specific in challenges). · Mahadev S et al. Prevalence of Celiac Disease in Patients With Iron Deficiency Anemia-A Systematic Review With Meta-analysis. Gastroenterology, 2018. PMID 29689265 (celiac disease in about 1 in 31 people with iron-deficiency anemia). · Molina-Infante J et al. Suspected Nonceliac Gluten Sensitivity Confirmed in Few Patients After Gluten Challenge in Double-Blind, Placebo-Controlled Trials. Clin Gastroenterol Hepatol, 2017. PMID 27523634 (10 blinded challenge trials; 16 percent gluten-specific; large nocebo response). · Skodje GI et al. Fructan, Rather Than Gluten, Induces Symptoms in Patients With Self-Reported Non-Celiac Gluten Sensitivity. Gastroenterology, 2018. PMID 29102613 (59 people; fructans caused more symptoms than gluten). · Biesiekierski JR et al. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology, 2013. PMID 23648697 (37 people; gluten-specific effects in 8 percent after a low-FODMAP diet). · Di Sabatino A et al. Small Amounts of Gluten in Subjects With Suspected Nonceliac Gluten Sensitivity: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial. Clin Gastroenterol Hepatol, 2015. PMID 25701700 (61 adults (59 completed), gluten capsules worsened symptoms versus placebo). · Shahbazkhani B et al. Non-Celiac Gluten Sensitivity Has Narrowed the Spectrum of Irritable Bowel Syndrome: A Double-Blind Randomized Placebo-Controlled Trial. Nutrients, 2015. PMID 26056920 (72 people with IBS; symptoms stayed controlled in 26 percent on gluten versus 84 percent on placebo). · Junker Y et al. Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4. J Exp Med, 2012. PMID 23209313 (amylase-trypsin inhibitors activate innate immunity in lab and animal studies). · Krouch D et al. Amylase trypsin inhibitors activation of toll-like receptor 4 revisited: The dominance of lipopolysaccharides contamination. Int J Biol Macromol, 2025. PMID 40288707 (lab study: bacterial endotoxin contamination may explain much of the immune effect attributed to amylase-trypsin inhibitors). · Black CJ et al. Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis. Gut, 2022. PMID 34376515 (IBS diets, 13 trials; low-FODMAP ranked first). · Cuffe MS et al. Efficacy of dietary interventions in irritable bowel syndrome: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol, 2025. PMID 40258374 (IBS diets, 28 trials; most evidence for low-FODMAP, the only diet better than a usual diet for bloating; mostly low or very low certainty). · König J et al. Randomized clinical trial: Effective gluten degradation by Aspergillus niger-derived enzyme in a complex meal setting. Sci Rep, 2017. PMID 29026170 (AN-PEP, 18 gluten-sensitive people; stomach gluten about 88 percent lower than placebo on the high dose). · Stefanolo JP et al. Effect of Aspergillus niger prolyl endopeptidase in patients with celiac disease on a long-term gluten-free diet. World J Gastroenterol, 2024. PMID 38617446 (AN-PEP, 40 people with celiac disease; stool gluten fragments not significantly reduced; exploratory). · Tack GJ et al. Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study. World J Gastroenterol, 2013. PMID 24124328 (AN-PEP celiac pilot; main outcome not met; two people worsened). · Rees D et al. A randomised, double-blind, cross-over trial to evaluate bread, in which gluten has been pre-digested by prolyl endoprotease treatment, in subjects self-reporting benefits of adopting a gluten-free or low-gluten diet. Br J Nutr, 2018. PMID 29508689 (AN-PEP-treated bread; no difference in symptoms). · Ido H et al. Combination of Gluten-Digesting Enzymes Improved Symptoms of Non-Celiac Gluten Sensitivity: A Randomized Single-blind, Placebo-controlled Crossover Study. Clin Transl Gastroenterol, 2018. PMID 30228265 (enzyme blend, 30 people, single-blind, run and funded by the enzyme maker). · Janssen G et al. Ineffective degradation of immunogenic gluten epitopes by currently available digestive enzyme supplements. PLoS One, 2015. PMID 26030273 (commercial digestive enzymes left immunogenic gluten fragments largely intact). · Krishnareddy S et al. Commercially available glutenases: a potential hazard in coeliac disease. Ther Adv Gastroenterol, 2017. PMID 28567117 (14 over-the-counter glutenase products; claims without scientific basis). · Murray JA et al. No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease. Gastroenterology, 2017. PMID 27864127 (latiglutenase phase 2 drug trial, 494 people with celiac disease; no difference from placebo). · Pultz IS et al. Gluten Degradation, Pharmacokinetics, Safety, and Tolerability of TAK-062, an Engineered Enzyme to Treat Celiac Disease. Gastroenterology, 2021. PMID 33741317 (TAK-062, engineered enzyme drug; phase 1 gluten breakdown, development later stopped). · European Medicines Agency. Paediatric investigation plan discontinuation notice for TAK-062 (Takeda), 17 September 2025: development in celiac disease discontinued after the phase 2 study TAK-062-2001 did not meet its primary endpoint. · Smecuol E et al. Exploratory, randomized, double-blind, placebo-controlled study on the effects of Bifidobacterium infantis natren life start strain super strain in active celiac disease. J Clin Gastroenterol, 2013. PMID 23314670 (B. infantis NLS in untreated celiac disease; exploratory symptom effects). · Klemenak M et al. Administration of Bifidobacterium breve Decreases the Production of TNF-α in Children with Celiac Disease. Dig Dis Sci, 2015. PMID 26134988 (B. breve in children with celiac disease; lower TNF-alpha, an inflammation marker; no symptom benefit reported). · Di Pierro F et al. Pilot study on non-celiac gluten sensitivity: effects of Bifidobacterium longum ES1 co-administered with a gluten-free diet. Minerva Gastroenterol Dietol, 2020. PMID 32397695 (B. longum ES1 in gluten sensitivity; small open-label pilot). · Barbaro MR et al. Serum zonulin and its diagnostic performance in non-coeliac gluten sensitivity. Gut, 2020. PMID 32060130 (zonulin higher in gluten sensitivity in one study; proposed by its authors as a marker, not a validated clinical test). · Ingrosso MR et al. Systematic review and meta-analysis: efficacy of peppermint oil in irritable bowel syndrome. Aliment Pharmacol Ther, 2022. PMID 35942669 (peppermint oil in IBS, 10 trials in 1,030 adults; very low certainty). · Bijkerk CJ et al. Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial. BMJ, 2009. PMID 19713235 (psyllium versus bran in 275 primary-care IBS patients; bran better than placebo only in month 3). · Vici G et al. Gluten free diet and nutrient deficiencies: A review. Clin Nutr, 2016. PMID 27211234 (nutrient shortfalls of gluten-free diets). · Larretxi I et al. Micronutrient Analysis of Gluten-Free Products: Their Low Content Is Not Involved in Gluten-Free Diet Imbalance in a Cohort of Celiac Children and Adolescent. Foods, 2019. PMID 31394809 (gluten-free breads, flakes and pasta lower in iron and B vitamins). · Wierdsma NJ et al. Vitamin and mineral deficiencies are highly prevalent in newly diagnosed celiac disease patients. Nutrients, 2013. PMID 24084055 (80 newly diagnosed celiac adults; 87 percent had at least one low nutrient value). · Raehsler SL et al. Accumulation of Heavy Metals in People on a Gluten-Free Diet. Clin Gastroenterol Hepatol, 2018. PMID 28223206 (higher blood mercury, lead, cadmium and urinary arsenic on gluten-free diets). · Lebwohl B et al. Long term gluten consumption in adults without celiac disease and risk of coronary heart disease: prospective cohort study. BMJ, 2017. PMID 28465308 (gluten intake not linked with heart disease in 110,017 adults).